A record for the reading desk
Ipamorelin
Aliases: Ipamorelin acetate
The recorded fields, their references, and a question worth keeping.
- Status
- Not FDA-approved
- Evidence label
- Randomized evidence
- Index topics
- Hormones
- Status as of
Record / 01
Recorded fields
- Mechanism
- A ghrelin-receptor agonist.
- Evidence
- A randomized postoperative-ileus trial did not show a significant efficacy advantage.
- Limitations
- That setting does not establish anti-aging or muscle-building benefit.
- Safety
- FDA flags safety uncertainties for injectable ipamorelin.
- Route context
- The cited trial used intravenous treatment after bowel surgery.
- Approval scope
- The reviewed FDA record identifies no approved ipamorelin product.
Reasoning / 02
A note for your reading
A sign being expected under an explanation is different from that explanation being likely whenever the sign appears. Imagine that several competing explanations could all produce the same sign. Observing it would leave a choice among them. To work backward responsibly, ask how readily each alternative could produce the sign and what other information bears on the alternatives. A useful note keeps the two directions separate: what an explanation predicts, and what an observation supports. Recognizing the difference helps prevent an expected observation from being treated as a unique answer.
Keep asking / 03
Three questions to carry forward
- Am I considering what the explanation predicts or what the observation supports?
- Could other explanations produce the same sign without the proposed explanation being true?
- What further information would help compare those alternatives after observing this sign?
Trace the record / 04
References
- FDA safety
FDA · Checked
- FDA ipamorelin
FDA · Checked
- Beck
PubMed · Checked